全文获取类型
收费全文 | 1604篇 |
免费 | 61篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 46篇 |
妇产科学 | 105篇 |
基础医学 | 199篇 |
口腔科学 | 6篇 |
临床医学 | 51篇 |
内科学 | 172篇 |
皮肤病学 | 28篇 |
神经病学 | 103篇 |
特种医学 | 21篇 |
外科学 | 372篇 |
综合类 | 117篇 |
预防医学 | 52篇 |
眼科学 | 4篇 |
药学 | 92篇 |
中国医学 | 19篇 |
肿瘤学 | 281篇 |
出版年
2023年 | 21篇 |
2022年 | 24篇 |
2021年 | 50篇 |
2020年 | 41篇 |
2019年 | 43篇 |
2018年 | 44篇 |
2017年 | 56篇 |
2016年 | 48篇 |
2015年 | 51篇 |
2014年 | 124篇 |
2013年 | 95篇 |
2012年 | 81篇 |
2011年 | 101篇 |
2010年 | 76篇 |
2009年 | 93篇 |
2008年 | 79篇 |
2007年 | 85篇 |
2006年 | 75篇 |
2005年 | 57篇 |
2004年 | 46篇 |
2003年 | 63篇 |
2002年 | 39篇 |
2001年 | 35篇 |
2000年 | 23篇 |
1999年 | 23篇 |
1998年 | 26篇 |
1997年 | 29篇 |
1996年 | 14篇 |
1995年 | 21篇 |
1994年 | 14篇 |
1993年 | 12篇 |
1992年 | 9篇 |
1991年 | 11篇 |
1990年 | 8篇 |
1989年 | 6篇 |
1988年 | 3篇 |
1987年 | 6篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 7篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1971年 | 1篇 |
排序方式: 共有1677条查询结果,搜索用时 281 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
《Actas urologicas espa?olas》2022,46(9):550-556
ObjectiveProstate cancer (PCa) is the second most common solid tumor in men and the fifth leading cause of cancer-related death. In advanced stage, palliative treatments are used instead of curative therapies. Therefore, finding predictive indicators seems crucial. Patients with castration-resistant prostate cancer (CRPC) that received Dx chemotherapy have been retrospectively reviewed. The aim of this study was to investigate whether docetaxel (Dx)-free interval could have a predictive value for PCa and influence other sequential therapies.Material and methodsThis clinical trial study was performed on 104 patients at Medeniyet University Oncology Clinic in 2018-2020. All CRPC patients had metastases, received Dx as first-line treatment and underwent androgen receptor axis targeted (ARAT) therapy after disease progression. We analyzed patients’ progression time after Dx therapy and the effects on sequential treatment.ResultsAfter Dx therapy, all patients received ARAT (abiraterone (ABI) n: 49 (47.1%) and enzalutamide (ENZ) n: 54 (51.9%)) as a second-line treatment, except for one patient who received cabazitaxel. There was a statistically significant relationship between the Dx-free interval and duration of response to ARAT (P<.001). The response time of ARAT treatment was <10.5 months in all patients whose Dx-free interval period was <9 months.ConclusionsOur findings support the theory that Dx-free interval can be a predictive factor for CRPC. CRPC disease can be classified as Dx-sensitive disease or Dx-resistance disease, based on the Dx-free interval. Decision on subsequent treatments could be made considering this information. 相似文献
3.
4.
《Allergology international》2022,71(4):432-436
Steroid hormones, especially glucocorticoids, androgens, and estrogens, have profound influence on immunity. Recent studies using cell-type specific steroid hormone receptor-deficient mice have revealed the precise roles of some of these hormones in the immune system. Glucocorticoids are known to have strong anti-inflammatory and immunosuppressive effects and pleiotropic effects on innate and adaptive immune responses. They suppress the production of inflammatory cytokines by macrophages and DCs and the production of IFN-γ by NK cells, thus inhibiting innate immunity. By contrast, glucocorticoids enhance the immune response by inducing the expression of IL-7R and CXCR4 in T cells and the accumulation of T cells in lymphoid organs in accordance with the diurnal change of the glucocorticoid concentration. Thus, glucocorticoids suppress innate immunity but enhance adaptive immunity. Androgens suppress the homeostasis and activation of ILC2s and the differentiation of Th2 and Th17 cells and enhance the suppressive function of Tregs, thereby alleviating allergic airway inflammation. Thus, these steroid hormones have pleiotropic functions in the immune system. Further investigations are awaited on the regulation of immunity and allergy by estrogens using cell-specific steroid hormone receptor-deficient mice. 相似文献
5.
W. S. L. Stebbings M. J. G. Farthing J. R. Puddefoot Elizabeth Anderson G. P. Vinson J. M. A. Northover R. F. M. Wood 《Journal of cancer research and clinical oncology》1988,114(2):208-211
Summary To evaluate the potential effect of androgens on the development and growth of human colorectal adenomas, the prevalence and concentration of cytosolic androgen receptors (AR) were analysed in 26 adenomas and 19 samples of normal colonic mucosa by a hybrid ligand receptor-binding assay. AR were detected in 7 of the adenomas (26.9%), and in 6 of the normal mucosa samples (31.6%). In the adenomas, AR levels demonstrated were low, ranging from 6 to 31 fmol/mg cytosol protein, and dissociation constants (Kds) ranged from 0.17–2.7x10-9
M. Of 13 adenomas excised from men, 6 (46%) had positive receptor activity, whereas only 1 of 13 (7.7%) from women was positive (P=0.03, Fisher's exact test). There was no correlation between AR titre and patient age, or between adenoma size and histological type or degree of dysplasia. In normal mucosa, AR levels ranged from 7 to 33 fmol/mg and Kds ranges from 0.24–3.1x10-9
M. There was no significant difference between either AR prevalence or levels in the adenomas and normal mucosa. The sex difference was exclusive to the adenoma. Endogenous androgen may play a role in adenoma development early in the promotional process. 相似文献
6.
7.
The binding of [3H]androgens and estrogens, and the metabolism of [3H]androgens, were studied in the spinal cord of the adult rat. High-affinity, specific binding sites for [3H]testosterone and [3H]estradiol were detected in cytosol fractions from the spinal cords of castrate animals. Equilibrium dissociation constants for reaction of these sites with their respective ligands were similar to those of androgen and estrogen receptors from other regions of the central nervous system. Nuclear binding of [3H]estradiol was observed in the spinal cord 1 h after intravenous administration of the isotope. Likewise, exchange assay demonstrated the presence of high-affinity androgen binding sites in spinal cord nuclei from orchidectomized, testosterone propionate treated animals. 5 alpha-Reductase activity in homogenates of the spinal cord was relatively high, approximately 3 times that in the pooled hypothalamus, preoptic area, septum and amygdala. However, in contrast to the latter brain regions, estrogen formation was not detectable in spinal cord tissue. No sex differences were observed in the metabolism of [3H]testosterone by spinal cord homogenates. These results confirm the presence of androgen and estrogen receptors in the rat spinal cord. The lack of detectable aromatase activity in the spinal cord is consistent with the hypothesis that the effects of circulating testosterone on spinal reflex function are mediated primarily through the androgen receptor system. 相似文献
8.
为研究雄激素和雌激素对心钠素基因表达的影响,给完整的、去势的雄性大鼠皮下注射丙酸睾丸酮或雌二醇,持续2周。用冷酚法提取心房总RNA,用α-~(32)P标记ANF—cD-NA探针,经RNA电泳转移杂交和斑点吸印杂交。结果表明去势后ANF—mRNA含量下降,睾丸酮和雌二醇均使ANF—mRNA增加,然而小剂量的睾丸酮、雌二醇对去势大鼠ANF基因表达作用还需进一步研究。 相似文献
9.
目的:探讨D期前列腺癌(PCa)患者药物去势治疗的效果与雄激素受体(AR)、前列腺特异性抗原(PSA)的相关性。方法:对33例D期PCa患者给予LHRH类似物 抗雄激素药物进行药物去势治疗,结合免疫组化进行统计分析。结果:AR、PSA与癌组织分化程度的之间的差异有统计学意义。Gleason不同评分组间血清PSA水平之间差异有统计学意义(P<0.05),PCa Gleason评分值与原位PSA免疫标记表达呈明显的负相关性(P<0.01);原位PSA免疫标记表达与血清PSA不具有相关性。结论:PCa组织中AR、PSA表达与D期PCa患者行药物去势疗法疗效有密切关系;血清PSA变化是监测PCa肿瘤复发与疗效的可靠瘤标。 相似文献
10.
前列腺癌去势术前后雄性激素变化的研究 总被引:7,自引:1,他引:6
目的 :观察前列腺癌去势术前后雄性激素的变化。 方法 :16例前列腺癌病人在手术前后分别采集血清样本 ,用放射免疫法测定睾酮 (T)、游离睾酮 (FT)、双氢睾酮 (DHT)的含量 ,进行对比分析。 结果 :手术前后 ,血清中T、FT、DHT浓度有非常明显的差异 ,手术后分别下降 92 .2 7%、92 .2 6%、5 8.3 6% ,以T、FT下降为主。根据 2次测定的结果采用配对t检验方法 ,P <0 .0 0 1。 结论 :去势术后 ,去除了血清中绝大部分T、FT ,而DHT仅下降5 8.3 6% ,应当继续使用雄性激素受体竞争剂 ,阻止残存的雄性激素作用 相似文献